Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 501

1.

Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons.

Mount MP, Lira A, Grimes D, Smith PD, Faucher S, Slack R, Anisman H, Hayley S, Park DS.

J Neurosci. 2007 Mar 21;27(12):3328-37.

2.

Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Hayley S, Crocker SJ, Smith PD, Shree T, Jackson-Lewis V, Przedborski S, Mount M, Slack R, Anisman H, Park DS.

J Neurosci. 2004 Feb 25;24(8):2045-53.

3.
4.
5.

Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Sawada H, Hishida R, Hirata Y, Ono K, Suzuki H, Muramatsu S, Nakano I, Nagatsu T, Sawada M.

J Neurosci Res. 2007 Jun;85(8):1752-61.

PMID:
17469135
6.

Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice.

Sugama S, Yang L, Cho BP, DeGiorgio LA, Lorenzl S, Albers DS, Beal MF, Volpe BT, Joh TH.

Brain Res. 2003 Feb 28;964(2):288-94.

PMID:
12576189
7.

Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action.

Kim YJ, Park HJ, Lee G, Bang OY, Ahn YH, Joe E, Kim HO, Lee PH.

Glia. 2009 Jan 1;57(1):13-23. doi: 10.1002/glia.20731.

PMID:
18661552
8.
9.
10.

Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease.

González H, Contreras F, Prado C, Elgueta D, Franz D, Bernales S, Pacheco R.

J Immunol. 2013 May 15;190(10):5048-56. doi: 10.4049/jimmunol.1203121. Epub 2013 Apr 15.

12.

Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons.

Gao HM, Hong JS, Zhang W, Liu B.

J Neurosci. 2002 Feb 1;22(3):782-90.

14.
15.
16.

Proteomic analysis of microglial contribution to mouse strain-dependent dopaminergic neurotoxicity.

McLaughlin P, Zhou Y, Ma T, Liu J, Zhang W, Hong JS, Kovacs M, Zhang J.

Glia. 2006 Apr 15;53(6):567-82.

PMID:
16419087
17.

Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease.

Duan W, Ladenheim B, Cutler RG, Kruman II, Cadet JL, Mattson MP.

J Neurochem. 2002 Jan;80(1):101-10.

18.

Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease.

Le W, Rowe D, Xie W, Ortiz I, He Y, Appel SH.

J Neurosci. 2001 Nov 1;21(21):8447-55.

19.

APP knockout attenuates microglial activation and enhances neuron survival in substantia nigra compacta after axotomy.

DeGiorgio LA, Shimizu Y, Chun HS, Cho BP, Sugama S, Joh TH, Volpe BT.

Glia. 2002 Apr 15;38(2):174-8.

PMID:
11948811
20.

Upregulation of microglial C1q expression has no effects on nigrostriatal dopaminergic injury in the MPTP mouse model of Parkinson disease.

Depboylu C, Schorlemmer K, Klietz M, Oertel WH, Weihe E, Höglinger GU, Schäfer MK.

J Neuroimmunol. 2011 Jul;236(1-2):39-46. doi: 10.1016/j.jneuroim.2011.05.006.

PMID:
21640391

Supplemental Content

Support Center